Blueprint Medicines Corporation BPMC reported fourth-quarter 2024 adjusted loss of 79 cents per share, wider than the Zacks ...

Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...

UBS initiated coverage of Celldex (CLDX) with a Buy rating and $44 price target The firm says KIT inhibition is “differentiated in the ...

Third Harmonic Bio, Inc. (NASDAQ:THRD) revealed results from its Phase 1 single and multiple ascending dose (SAD/MAD) trial ...

The company explained that, in a comparison of the effects of YH35324 and Xolair in patients with chronic spontaneous urticaria (CSU), patients administered YH35324 showed significantly better symptom ...

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority ...

If your legs or other parts of your body itch when exposed to cold temperatures, it could be a sign of a health condition - ...

Bio, Inc. (NASDAQ:THRD), a clinical-stage biopharmaceutical company with a market capitalization of $209.5 million, today announced positive Phase 1 clinical trial results for its drug candidate ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...

Dr Sermed Mezher, a GP in the UK, explained how a certain feeling in the cold months could be a sign of a potentially ...

If your legs itch whenever you head out into the cold, it could be a sign of a health condition that can be life-threatening ...